Recombinant Mycoplasma genitalium Uncharacterized protein MG415 (MG415)

Shipped with Ice Packs
In Stock

Description

Introduction to Mycoplasma genitalium and MG415

Mycoplasma genitalium is a bacterium known for being one of the smallest self-replicating organisms and is associated with various genitourinary diseases, including urethritis and other sexually transmitted infections . Despite its minimal genome, M. genitalium has adapted to survive and thrive in human hosts, partly due to its ability to express proteins that facilitate its survival and pathogenicity.

Overview of Mycoplasma genitalium Proteins

Mycoplasma genitalium proteins are crucial for its survival and pathogenicity. For example, the MgPa adhesin, encoded by the mgpB gene, plays a significant role in the bacterium's adherence to host cells . Another protein, MG_454, acts as an organic hydroperoxide reductase, helping the bacterium resist oxidative stress .

ProteinFunctionReference
MgPaAdhesion to host cells
MG_454Organic hydroperoxide reductase

Challenges in Studying Uncharacterized Proteins

Studying uncharacterized proteins like MG415 poses several challenges:

  1. Limited Literature: There is a lack of specific studies focusing on MG415, making it difficult to determine its function or role in M. genitalium.

  2. Genomic Complexity: Despite M. genitalium's minimal genome, the complexity of its genetic makeup and the interactions between its proteins can be intricate .

  3. Experimental Approaches: Investigating uncharacterized proteins often requires advanced molecular biology techniques, such as gene knockout studies or protein expression assays, which can be resource-intensive.

Research Directions for MG415

To better understand MG415, future research could focus on:

  1. Functional Genomics: Using high-throughput sequencing and bioinformatics tools to predict potential functions based on sequence homology.

  2. Protein Expression and Purification: Recombinant expression of MG415 in a suitable host, followed by purification and characterization using techniques like Western blotting or mass spectrometry.

  3. Cellular Assays: Investigating the impact of MG415 on host cell interactions or survival using cell culture models.

References

- Mycoplasma genitalium Protein of Adhesion Promotes the Early Proliferation of Human Urothelial Cells by Interacting with RPL35.
- Assessing the performance of commercial reagent antibodies.
- Analysis Identifying Common and Distinct Sequences among Texas Clinical Strains of Mycoplasma genitalium.
- Detection of human IgG antibodies against Mycoplasma genitalium.
- Polyglutamine expansion, protein aggregation, proteasome activity.
- The Mycoplasma genitalium MG_454 Gene Product Resists Killing by Organic Hydroperoxides.
- Essential genes of a minimal bacterium.

Product Specs

Form
Supplied as a lyophilized powder.
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for fulfillment based on your needs.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notification and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference.
Shelf Life
Shelf life depends on various factors, including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its inclusion.
Synonyms
MG415; MG_525; Uncharacterized protein MG415
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
26-664
Protein Length
Full Length of Mature Protein
Species
Mycoplasma genitalium (strain ATCC 33530 / G-37 / NCTC 10195)
Target Names
MG415
Target Protein Sequence
SKLIDTNLYLVKDDFQSQNQLTIATNQLAKIIVNQIEFDSNSLIANPTTVLNKELIGSKI TPKLKFSDQFSNAIEMVSKLNQEFDQLANKDKTFFQFALDLLEKQEESKFDFEPKDERID AIFFLSNLININPKQEKTLNFIRILPNLIKSIFKDTTITINIKIGGKNKVITFIENGSNV FLLSDVENFLNADQTGINFYEIEFLTFDFIVVNKTGWTLKNQPVDSFFKSVKNLPSIQKT KNGFQYSLKFRSEYNEHHILKDHFLIPIVTNQKNFSVNDIEKNGLNSYQREQITYAIKNS FTSQKENNLNISSATIKYIKDPEKLIKKSLIKPSVKNGIFYVSAQIINSNDLTKWGSKND SEIIKDKMYFLEQNKNFPAIRTYLFQMRTKKLVLNVNDIWFKSSGDKLRVIVNNVEIDEF NPKENNTSFFESYEVHINDYFSLANKELLIKKLNLALSEMNLLIDKKKSSLDLFPKEIKL TTLKINSSLHFYLNVDAIKNQLNIEVNISKNRLTSLVYDIAIKNENELQIRTTNNYLNKY IWFDLDKKNNQKLKNELKLFLSLKKFQFKKEPNFSLKKNSYSFQIDKIIQSNSEDKKTDI IVYLIIGFSVLVLFITVFIYFHKWNKKQKMIKNKTRDNF
Uniprot No.

Target Background

Database Links

KEGG: mge:MG_525

Protein Families
MG414/MG415 family
Subcellular Location
Cell membrane; Single-pass membrane protein.

Q&A

What is MG415 and what is known about its function in Mycoplasma genitalium?

MG415 is a conserved hypothetical protein encoded by the Mycoplasma genitalium genome. While its exact function remains uncharacterized, experimental evidence indicates it may play a role in growth regulation, as mutants with disruptions in this gene demonstrate doubling times up to 20% faster than wild-type M. genitalium strains . This protein is classified as non-essential, as viable transposon insertion mutants have been successfully isolated and cultured. The gene appears to be frequently mutated in both primary colonies and subcolonies during transposon mutagenesis experiments, suggesting it may be a hotspot for genetic manipulation .

To study this protein, researchers should consider:

  • Generating recombinant MG415 using expression systems optimized for mycoplasma proteins

  • Performing comparative growth analyses between wild-type and MG415-disrupted strains

  • Employing protein interaction studies to identify binding partners

  • Conducting complementation studies to confirm phenotypes associated with gene disruption

How does MG415 relate to the concept of a minimal bacterial genome?

MG415 represents an interesting case study in minimal genome research. Mycoplasma genitalium possesses the smallest genome of any organism that can be grown in pure culture, making it a model for understanding the minimal gene set required for cellular life . Although MG415 has been identified as non-essential through transposon mutagenesis studies, its disruption significantly impacts cellular growth rates, highlighting the complex relationships between genes classified as "essential" versus those that are "fitness-enhancing" .

When investigating MG415 in relation to minimal genome concepts, researchers should:

  • Consider the methodological approach used to define gene essentiality (transposon mutagenesis vs. deletion studies)

  • Examine the growth conditions under which essentiality is determined

  • Evaluate MG415's conservation across other minimal genome bacteria

  • Assess potential functional redundancy with other proteins that may mask essentiality under standard laboratory conditions

What methods are recommended for expressing and purifying recombinant MG415 protein?

For successful expression and purification of recombinant MG415:

  • Expression system selection: Consider using E. coli BL21(DE3) with codon optimization for the AT-rich mycoplasma genome. Alternative systems include cell-free protein synthesis if toxicity is observed.

  • Vector design: Incorporate a cleavable affinity tag (His6, GST, or MBP) to facilitate purification and potentially enhance solubility.

  • Expression conditions: Test multiple induction temperatures (16°C, 25°C, 37°C) and IPTG concentrations (0.1-1.0 mM) to optimize soluble protein yield.

  • Purification protocol:

    • Initial capture: Affinity chromatography using the incorporated tag

    • Secondary purification: Size exclusion chromatography

    • Optional polishing: Ion exchange chromatography

  • Buffer optimization: Screen various buffer compositions to enhance protein stability:

    • pH range: 6.5-8.0

    • Salt concentration: 150-500 mM NaCl

    • Additives: 5-10% glycerol, reducing agents (DTT or TCEP)

This methodological approach should be optimized based on initial expression trials and protein behavior during purification steps.

How can researchers design experiments to elucidate the molecular mechanism behind MG415 mutants' accelerated growth phenotype?

To investigate the molecular basis of accelerated growth in MG415 mutants, researchers should implement a multi-faceted experimental approach:

  • Transcriptomic analysis: Compare RNA-seq profiles between wild-type and MG415 mutant strains to identify differentially expressed genes that may contribute to the growth phenotype. Focus analysis on metabolic pathways, cell division genes, and stress response systems.

  • Metabolomic profiling: Quantify metabolites using LC-MS/MS to identify altered metabolic fluxes in mutant strains, potentially revealing how MG415 influences cellular metabolism.

  • Protein interaction studies:

    • Employ co-immunoprecipitation followed by mass spectrometry to identify MG415 binding partners

    • Use bacterial two-hybrid or proximity labeling methods to confirm interactions

    • Perform structural studies (X-ray crystallography or cryo-EM) if protein interactions are identified

  • Growth kinetics analysis: Track growth under various nutrient limitations and stress conditions to characterize the environmental parameters that influence the MG415 mutant phenotype .

  • Cell morphology and division analysis: Utilize high-resolution microscopy to examine differences in cell size, shape, and division patterns between wild-type and MG415 mutant strains.

The experimental design should include appropriate controls, biological replicates (minimum n=3), and statistical analysis using ANOVA or similar methods to ensure robust interpretation of results .

What are the considerations for analyzing potential functional redundancy between MG414 and MG415?

Given that both MG414 and MG415 mutants demonstrate similar accelerated growth phenotypes and are frequently disrupted in transposon mutagenesis studies , investigating their potential functional redundancy requires careful experimental planning:

  • Double mutant construction: Generate MG414/MG415 double mutants using sequential transposon mutagenesis or CRISPR-based approaches adapted for mycoplasmas. If double mutants are non-viable while single mutants are viable, this would strongly support functional redundancy.

  • Complementation analysis:

    • Express MG414 in MG415 mutants and vice versa

    • Assess whether cross-complementation rescues mutant phenotypes

    • Design chimeric proteins containing domains from both proteins to identify functional regions

  • Protein structure and homology analysis:

    • Conduct bioinformatic analysis to identify shared domains or motifs

    • Use structural prediction tools to compare predicted protein structures

    • Investigate evolutionary relationships across mycoplasma species

  • Transcriptional regulation analysis:

    • Determine if MG414 and MG415 are co-regulated or part of the same operon

    • Identify transcription factors that may regulate both genes

    • Analyze promoter regions for shared regulatory elements

  • Systematic interaction mapping:

    • Compare protein interaction networks for both proteins

    • Identify shared interaction partners that might explain functional overlap

The experimental design should include factorial approaches to test for interaction effects between the two genes, as described in appropriate statistical frameworks for gene interaction studies .

How can researchers accurately interpret growth data from MG415 mutant strains compared to wild-type M. genitalium?

When analyzing growth data from MG415 mutant strains compared to wild-type, researchers should implement robust analytical approaches:

  • Growth curve analysis methodology:

    • Employ automated growth monitoring systems with frequent measurements (every 1-2 hours)

    • Calculate multiple growth parameters beyond doubling time (lag phase duration, maximum growth rate, carrying capacity)

    • Fit data to appropriate growth models (logistic, Gompertz, etc.) for parameter extraction

  • Statistical considerations:

    • Use repeated measures ANOVA or mixed-effects models to analyze time-series growth data

    • Ensure assumptions of normality and homoscedasticity are met or use appropriate transformations

    • Include a minimum of 6-8 biological replicates per strain to account for variability

  • Control for confounding factors:

    • Standardize inoculum density and growth phase of starter cultures

    • Control for potential transposon effects using strains with insertions in neutral genomic locations

    • Monitor pH and nutrient depletion throughout growth experiments

  • Data visualization:

    • Present growth curves with error bars representing standard error

    • Use semi-log plots to clearly visualize exponential growth phases

    • Consider heat maps for visualizing growth across multiple conditions

  • Integration with other data types:

    • Correlate growth parameters with transcriptomic or metabolomic changes

    • Analyze relationship between growth rate and other phenotypic characteristics

    • Consider using principal component analysis to identify major sources of variation in multifactorial experiments

This comprehensive approach will help distinguish genuine biological effects from technical variability and allow for accurate interpretation of the MG415 mutant phenotype .

What are the optimal experimental controls for studying MG415 function in Mycoplasma genitalium?

When designing experiments to study MG415 function, researchers should implement the following control strategies:

  • Genetic controls:

    • Wild-type M. genitalium strain (preferably from the same lineage as mutants)

    • Control transposon mutants in non-essential genes with no growth phenotype

    • Complemented mutant strains expressing MG415 from a plasmid or chromosomal integration

    • Mutants with transposon insertions in different regions of the MG415 gene to assess domain-specific functions

  • Technical controls:

    • Include biological replicates (n≥3) and technical replicates (n≥3) for all experiments

    • Implement randomized block designs where appropriate to minimize batch effects

    • Include time-series sampling to capture dynamic processes rather than endpoint measurements

  • Validation controls:

    • Confirm transposon insertion sites by sequencing

    • Verify absence of MG415 expression using RT-qPCR and/or western blotting

    • Check for potential polar effects on adjacent genes

    • Verify strain purity through culture and PCR-based methods

  • Environmental controls:

    • Standardize growth media composition across experiments

    • Control temperature, pH, and atmospheric conditions

    • Consider testing multiple growth conditions to assess condition-dependent phenotypes

  • Data analysis controls:

    • Include appropriate statistical tests based on experimental design

    • Use power analysis to determine adequate sample sizes

    • Apply correction for multiple testing when screening for differential effects

This comprehensive control strategy will help distinguish specific effects of MG415 disruption from background variation and technical artifacts .

How should researchers approach transposon mutagenesis studies targeting MG415 and related genes?

For effective transposon mutagenesis studies of MG415 and related genes in M. genitalium:

  • Transposon selection and design:

    • Use well-characterized transposons like Tn4001 that have been validated in mycoplasmas

    • Consider transposons with outward-facing promoters for potential polar effects analysis

    • Include selectable markers appropriate for mycoplasma (tetracycline or gentamicin resistance)

  • Mutation verification strategy:

    • Implement PCR-based verification of insertion sites

    • Sequence across insertion junctions to confirm precise location

    • Quantify potential wild-type contamination using qPCR (aim for <1% wild-type sequence)

    • Verify absence of protein expression using antibodies or tagged constructs

  • Clone isolation and purification:

    • Perform filter cloning or limiting dilution to ensure clonal populations

    • Monitor for potential transposon jumping to secondary sites

    • Establish multiple independent mutant lines for each target gene

  • Phenotypic characterization:

    • Implement standardized growth curve analysis

    • Assess colony morphology and adherence properties

    • Evaluate stress responses and metabolic capabilities

    • Consider co-culture experiments to detect complementation effects

  • Data tracking and management:

    • Maintain detailed records of colony appearance timing

    • Document subcolony derivation and relationships

    • Track mutant behavior through multiple passages

    • Record any instances of growth adaptation or phenotypic changes over time

This methodological approach acknowledges the challenges specific to mycoplasma mutagenesis studies, including the tendencies for transposon hopping and the possible complementation effects in mixed populations .

What considerations should be made when designing growth experiments with MG415 mutant strains?

When designing growth experiments with MG415 mutant strains, researchers should address several key methodological considerations:

  • Growth medium optimization:

    • Use standardized media formulations (SP4 medium is common for mycoplasmas)

    • Consider testing minimal media formulations to reveal metabolic dependencies

    • Note that some mutants may require specific media components (e.g., MG066 mutants lyse in PBS and require SP4 or serum)

  • Growth monitoring approaches:

    • Implement automated systems for continuous measurement where possible

    • For adherent cultures, standardize surface area and material (plastic vs. glass)

    • Account for differential adherence properties (MG185 mutants float rather than adhere)

    • Consider using metabolic indicators (alamarBlue, MTT) as complementary growth measures

  • Experimental design structure:

    • Use factorial designs when testing multiple variables (e.g., temperature, pH, nutrients)

    • Implement randomized complete block designs to control for batch effects

    • Consider repeated measures designs for time-course experiments

    • Use Latin square designs when testing multiple factors with limited resources

  • Sample size and replication strategy:

    • Perform power analysis to determine appropriate replicate numbers

    • Include both biological replicates (different cultures) and technical replicates

    • Account for potential variability in mutant behavior in sample size calculations

  • Growth data collection:

    • Measure multiple growth parameters (lag phase, doubling time, maximum density)

    • Include microscopic examination for morphological changes

    • Consider flow cytometry for cell size and granularity assessment

    • Document any unusual growth characteristics (clumping, chain formation, etc.)

This comprehensive approach to growth experiment design will enable robust characterization of the MG415 mutant phenotype across various conditions and allow for meaningful comparisons between mutant and wild-type strains .

How should researchers approach comparative genomic analysis to understand MG415 conservation and evolution?

To effectively analyze MG415 conservation and evolution:

  • Sequence alignment and homology analysis:

    • Identify MG415 homologs across mycoplasma species and other bacteria using BLAST and HMM-based approaches

    • Use multiple sequence alignment tools (MUSCLE, MAFFT, or T-Coffee) to align homologs

    • Calculate sequence identity and similarity scores to quantify conservation

    • Identify conserved domains or motifs that may suggest function

  • Phylogenetic analysis:

    • Construct phylogenetic trees using maximum likelihood or Bayesian methods

    • Test multiple evolutionary models and select the best fit using AIC or BIC criteria

    • Implement bootstrap analysis (1000+ replicates) to assess branch support

    • Compare MG415 phylogeny with species phylogeny to detect horizontal gene transfer or unusual evolutionary patterns

  • Synteny and genomic context analysis:

    • Examine gene neighborhood conservation across species

    • Identify co-evolved gene clusters that may suggest functional relationships

    • Analyze promoter regions and regulatory elements for conservation

  • Selective pressure analysis:

    • Calculate dN/dS ratios to identify signatures of selection

    • Use sliding window analysis to identify regions under different selective pressures

    • Apply branch-site models to detect lineage-specific selection

  • Structure-based evolutionary analysis:

    • Map sequence conservation onto predicted protein structures

    • Identify structurally conserved regions that may be functionally important

    • Analyze co-evolution of amino acid residues to predict functional interactions

This comprehensive approach will provide insights into MG415's evolutionary history and potential functional constraints, informing experimental design for functional characterization studies.

What statistical approaches are most appropriate for analyzing phenotypic differences between wild-type and MG415 mutant strains?

For robust statistical analysis of phenotypic differences between wild-type and MG415 mutant strains:

  • Growth curve analysis:

    • Fit growth data to appropriate models (logistic, Gompertz, or Richards)

    • Extract parameters (maximum growth rate, lag phase, carrying capacity)

    • Compare parameters using t-tests (for single comparisons) or ANOVA (for multiple comparisons)

    • Consider non-linear mixed-effects models for time-series data with repeated measures

  • Multi-factor experimental analysis:

    • Use factorial ANOVA to analyze experiments with multiple variables (strain, media, temperature)

    • Apply appropriate post-hoc tests (Tukey HSD, Dunnett's) for pairwise comparisons

    • Check ANOVA assumptions (normality, homoscedasticity) and transform data if necessary

    • Consider robust alternatives (Welch's ANOVA, permutation tests) if assumptions cannot be met

  • High-dimensional data analysis:

    • For transcriptomic data: Use DESeq2 or edgeR with appropriate false discovery rate control

    • For metabolomic data: Apply multivariate methods (PCA, PLS-DA) followed by univariate testing

    • For proteomics: Consider specialized statistical approaches that account for peptide-level information

  • Sample size and power considerations:

    • Conduct a priori power analysis to determine required sample sizes

    • Report effect sizes (Cohen's d, η²) in addition to p-values

    • Consider issues of multiple testing and apply appropriate corrections (Bonferroni, Benjamini-Hochberg)

    • Set significance thresholds based on experimental context and hypothesis type

  • Data visualization for statistical interpretation:

    • Use boxplots or violin plots to show distributions

    • Include individual data points to show variability

    • Implement forest plots for effect size comparisons

    • Create interaction plots for factorial designs

This comprehensive statistical approach will ensure robust and reproducible analysis of phenotypic differences, facilitating accurate interpretation of MG415's functional role .

How can researchers integrate transcriptomic and proteomic data to develop functional hypotheses about MG415?

To effectively integrate multi-omics data for MG415 functional characterization:

  • Coordinated experimental design:

    • Collect transcriptomic and proteomic samples from the same biological replicates

    • Include time-series sampling to capture dynamic responses

    • Standardize growth conditions and sampling protocols

    • Include appropriate controls for both data types

  • Data pre-processing and normalization:

    • Apply platform-specific normalization (TPM/FPKM for RNA-seq, intensity-based for proteomics)

    • Perform batch correction if samples are processed in multiple batches

    • Filter low-quality or low-confidence measurements

    • Transform data appropriately for downstream integration (log transformation, scaling)

  • Correlation analysis approaches:

    • Calculate transcript-protein correlation globally and for specific pathways

    • Identify discordant genes (high transcript/low protein or vice versa)

    • Cluster genes based on transcript-protein correlation patterns

    • Apply time-lagged correlation for time-series data

  • Pathway and network integration:

    • Map transcriptomic and proteomic changes to metabolic pathways

    • Identify enriched biological processes using Gene Ontology analysis

    • Construct protein-protein interaction networks incorporating expression data

    • Apply network propagation algorithms to identify affected subnetworks

  • Causal modeling and hypothesis generation:

    • Use Bayesian network approaches to infer causality

    • Apply machine learning methods to identify predictive features

    • Develop testable hypotheses based on integrated analysis

    • Prioritize validation experiments based on confidence and biological significance

This integrated approach will provide a systems-level understanding of MG415 function, revealing its potential roles in cellular processes and identifying the most promising hypotheses for experimental validation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.